University of Washington
Seattle, Washington, 98195, United States
NCT Number: NCT03429465
The aim of the study is to determine whether a neuroscience-inspired cognitive remediation video game (EVO) that targets the cognitive control network (CCN) will improve executive functioning (EF) and resilience to psychiatric symptoms in typically developing 6th grade students, unselected for specific psychiatric symptoms. The primary goals are to 1) determine if EVO will result in improved EF and lower internalizing (e.g., mood, anxiety) and externalizing (e.g., attention deficit/hyperactivity disorder, AD/HD) psychiatric symptoms, 2) evaluate whether the benefit experienced by youth changes depending on their level of life stress (e.g., academic or social difficulties), 3) determine if EVO will promote resilience to stress. The investigators will measure EF, symptoms, and stress using self- and parent-report questionnaires. Other secondary outcomes include information on behavior in the classroom and academic performance (i.e., grades) that we will collect via school records. The investigators hypothesize that engagement with EVO 20-minutes per day, 5-days a week across 4-weeks will improve EF, lower psychiatric symptoms, improve academic/behavioral functioning at school, and decrease maladaptive responses to stress.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Seattle, Washington, 98195, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
EVO (formerly called Neuroracer) is a neuroscience-inspired plasticity trainings in the form of a video driving game that uses adaptive algorithms and dual-tasking paradigms to target the CCN. Work from our group (Project:EVO) recently showed that 4 weeks of EVO training is associated with increased neural recruitment in brain regions associated with CNN, superior improvement in cognitive control performance (i.e., working memory, sustained attention) when compared to an evidence-based psychotherapy (Problem-Solving Therapy), and improved depression outcomes similar to Problem-Solving Therapy among older adults (Areán, Hallgren, Jordan, Gazzaley, Atkins, Heagerty, & Anguera, 2016; Journal of Medical Internet Research).
Time frame: Measured 5 times across 5 months
Measuring Executive Function (e.g., attention, working memory) via parent-report of children's symptoms.
Time frame: Measured 5 times across 5 months
Measuring difficulties with attention (i.e., attention deficit/hyperactivity disorder), oppositionality, and conduct at home and school as measured by parent-report on children's behavior.
Time frame: Measured 5 times across 5 months
depression symptoms measured with self- and parent- report
Time frame: Measured 5 times across 5 months
Measuring self- and parent-reported symptoms of anxiety.
Time frame: Measured 5 times across 5 months
Measuring self-reported cognitive aspects of emotion regulation (e.g., rumination, positive reappraisal).
University of Washington
Other
Acronym: TRY
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04551976
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial DetailsNCT04925453
Attention Concentration Difficulty, Attention Impaired
San Diego, California, United States
View Trial DetailsNCT03125447
Attention Concentration Difficulty, Mobility Limitation
Nancy, France
View Trial DetailsNCT03882957
Attention Concentration Difficulty, Body Weight
Lebanon, New Hampshire, United States
View Trial Details